[The possible endometrial risk of ovarian stimulation. Apropos of 3 cases].
Three cases of adenomatous hyperplasia of the endometrium--one of them degenerated--have been reported in young women provided with ovulation stimulation. The association between these hormonal therapies and the adenocarcinoma or its antecedents signs, is particularly disturbing. However, it's difficult to establish a relationship between cause and effect. Indeed the women who suffer from an ovarian sterility are a group exposed to a cancer of the endometrium independently of any other iatrogenic agent. The method of detection is yet to be found, as is the mode of conduct which can reconcile the risk of a carcinoma and the desire of pregnancy.
Miannay
E
E
Service de Gynécologie, Maternité Henri Salengro, Lille.
Boutemy
J J
JJ
Leroy-Billiard
M
M
Gasnault
J P
JP
Leroy
J L
JL
D000230:Adenocarcinoma / Q000139:chemically induced; D000328:Adult; D006063:Chorionic Gonadotropin / Q000009:adverse effects; D002996:Clomiphene / Q000009:adverse effects; D004714:Endometrial Hyperplasia / Q000139:chemically induced*; D016889:Endometrial Neoplasms / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008596:Menotropins / Q000009:adverse effects; D010062:Ovulation Induction / Q000009:adverse effects*; D012307:Risk Factors
D006063:Chorionic Gonadotropin; D002996:Clomiphene; D008596:Menotropins
Du risque endométrial de la stimulation ovarienne. A propos de trois cas.